Emergence of insulin resistance following empirical glibenclamide therapy: a case report of neonatal diabetes with a recessive INS gene mutation.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620681
Title:
Emergence of insulin resistance following empirical glibenclamide therapy: a case report of neonatal diabetes with a recessive INS gene mutation.
Authors:
Yildiz, M.; Akcay, T.; Aydin, B.; Akgun, A.; Dogan, B. B.; De Franco, E.; Ellard, Sian ( 0000-0002-7620-5526 ) ; Onal, H.
Abstract:
As KATP channel mutations are the most common cause of neonatal diabetes mellitus (NDM) and patients with these mutations can be treated with oral sulfonylureas, empiric therapy is a common practice for NDM patients.
Citation:
Emergence of insulin resistance following empirical glibenclamide therapy: a case report of neonatal diabetes with a recessive INS gene mutation. 2018, 31 (3):345-348 J. Pediatr. Endocrinol. Metab.
Publisher:
De Gruyter
Journal:
Journal of pediatric endocrinology & metabolism : JPEM
Issue Date:
28-Mar-2018
URI:
http://hdl.handle.net/11287/620681
DOI:
10.1515/jpem-2017-0325
PubMed ID:
29305569
Additional Links:
https://www.degruyter.com/doi/10.1515/jpem-2017-0325
Type:
Case Report
Language:
en
ISSN:
2191-0251
Appears in Collections:
Molecular Genetics; 2018 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorYildiz, M.en
dc.contributor.authorAkcay, T.en
dc.contributor.authorAydin, B.en
dc.contributor.authorAkgun, A.en
dc.contributor.authorDogan, B. B.en
dc.contributor.authorDe Franco, E.en
dc.contributor.authorEllard, Sianen
dc.contributor.authorOnal, H.en
dc.date.accessioned2018-05-08T08:48:24Z-
dc.date.available2018-05-08T08:48:24Z-
dc.date.issued2018-03-28-
dc.identifier.citationEmergence of insulin resistance following empirical glibenclamide therapy: a case report of neonatal diabetes with a recessive INS gene mutation. 2018, 31 (3):345-348 J. Pediatr. Endocrinol. Metab.en
dc.identifier.issn2191-0251-
dc.identifier.pmid29305569-
dc.identifier.doi10.1515/jpem-2017-0325-
dc.identifier.urihttp://hdl.handle.net/11287/620681-
dc.description.abstractAs KATP channel mutations are the most common cause of neonatal diabetes mellitus (NDM) and patients with these mutations can be treated with oral sulfonylureas, empiric therapy is a common practice for NDM patients.en
dc.language.isoenen
dc.publisherDe Gruyteren
dc.relation.urlhttps://www.degruyter.com/doi/10.1515/jpem-2017-0325en
dc.rightsArchived with thanks to Journal of pediatric endocrinology & metabolism : JPEMen
dc.subjectWessex Classification Subject Headings::Oncology. Pathology.::Geneticsen
dc.titleEmergence of insulin resistance following empirical glibenclamide therapy: a case report of neonatal diabetes with a recessive INS gene mutation.en
dc.typeCase Reporten
dc.identifier.journalJournal of pediatric endocrinology & metabolism : JPEMen
dc.type.versionPublisheden

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.